Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering NCGC00024675-06.

Client Email

Product

NCGC00024675-06
HEALTH CANADA PATENTS

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

NCGC00024675-06

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 8 USDMF, 4 CEP/COS, 1 EU WC, 1 KDMF, 7 NDC API, 7 Listed Suppliers, $ API Reference Price

13 API Suppliers
8 USDMF
4 CEP/COS
1 EU WC
1 KDMF
7 NDC API
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

53 FDF Dossiers, 11 FDA Orange Book, 31 Europe, 1 Canada, 2 South Africa, 8 Listed Dossiers

53 FDF Dossiers
11 FDA Orange Book
31 Europe
1 Canada
2 South Africa
8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 6MG/ML

SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;ORAL - 6MG/ML

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 13 SPI Pharma, 2 Seqens, 7 DKSH, 2 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 1 Clariant, 10 Corel Pharma Chem, 2 Finar, 5 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 3 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 14 Roquette, 7 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives, 28 Fillers, Diluents & Binders, 21 Controlled & Modified Release, 18 Film Formers & Plasticizers, 14 Taste Masking, 13 Topical, 13 Parenteral, 12 Thickeners and Stabilizers, 12 Chewable & Orodispersible Aids, 11 Direct Compression, 9 Empty Capsules, 8 Solubilizers, 6 Granulation, 5 Coloring Agents, 4 Co-Processed Excipients, 4 Disintegrants & Superdisintegrants, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Emulsifying Agents, 2 Rheology Modifiers, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

46 Coating Systems & Additives
28 Fillers, Diluents & Binders
21 Controlled & Modified Release
18 Film Formers & Plasticizers
14 Taste Masking
13 Topical
13 Parenteral
12 Thickeners and Stabilizers
12 Chewable & Orodispersible Aids
11 Direct Compression
9 Empty Capsules
8 Solubilizers
6 Granulation
5 Coloring Agents
4 Co-Processed Excipients
4 Disintegrants & Superdisintegrants
4 Vegetarian Capsules
4 API Stability Enhancers
2 Emulsifying Agents
2 Rheology Modifiers
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

11 NEWS #PharmaBuzz

11 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 25 Finished Drug Prices

2 US Medicaid Prescriptions
25 Finished Drug Prices

MARKET PLACE

9 APIs, 3 FDF Dossiers

9 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 1 Health Canada Patents

6 US Patents
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 3 Others

3 EDQM
3 USP
3 Others

$ API Ref.Price (USD/KG) : 323 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Blank

filter Patent Reset all filters

1 All

01 11220424

filter Product Reset all filters

1 All

01 1Blank

filter Dosage Reset all filters

1 All

01 1Blank

filter Exp Date Reset all filters

1 All

01 12004-04-14

US Patents
Health Canada Patents

Product Main Page

01

Nimodipine

AAPS 2024

Not Confirmed

Country

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2004-04-14

Date Granted :

Brand Name :

Patent Number : 1220424

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2004-04-14

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?